发明名称 ISOINDOLINONE COMPOUNDS AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS
摘要 The present invention relates to isoindolinone compounds. The isoindolinone compounds are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of isoindolinone compounds as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.
申请公布号 WO2015150565(A1) 申请公布日期 2015.10.08
申请号 WO2015EP57415 申请日期 2015.04.02
申请人 SANOFI 发明人 SCHWINK, LOTHAR;BUNING, CHRISTIAN;GLOMBIK, HEINER;GOSSEL, MATTHIAS;KADEREIT, DIETER;HALLAND, NIS;LOHMANN, MATTHIAS;PÖVERLEIN, CHRISTOPH;RITTER, KURT
分类号 C07D401/14;A61K31/404;A61K31/41;A61K31/4196;A61K31/42;A61K31/421;A61K31/425;A61K31/4439;A61P3/00;C07D403/04;C07D413/14;C07D417/14 主分类号 C07D401/14
代理机构 代理人
主权项
地址